These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7975265)

  • 1. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.
    Brokaw JL; Yee CL; Münger K
    Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
    Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
    Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of transformation by the human papillomaviruses.
    Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R
    Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells.
    Braspenning J; Marchini A; Albarani V; Levy L; Ciccolini F; Cremonesi C; Ralston R; Gissmann L; Tommasino M
    Oncogene; 1998 Feb; 16(8):1085-9. PubMed ID: 9519882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The viral oncoproteins Ad5 E1A, HPV16 E7 and SV40 TAg bind a common region of the TBP-associated factor-110.
    Mazzarelli JM; Atkins GB; Geisberg JV; Ricciardi RP
    Oncogene; 1995 Nov; 11(9):1859-64. PubMed ID: 7478615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein.
    Münger K; Basile JR; Duensing S; Eichten A; Gonzalez SL; Grace M; Zacny VL
    Oncogene; 2001 Nov; 20(54):7888-98. PubMed ID: 11753671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8.
    Yamashita T; Segawa K; Fujinaga Y; Nishikawa T; Fujinaga K
    Oncogene; 1993 Sep; 8(9):2433-41. PubMed ID: 8395681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of p53 transcriptional activity by the HPV E7 proteins.
    Massimi P; Banks L
    Virology; 1997 Jan; 227(1):255-9. PubMed ID: 9007083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
    Armstrong DJ; Roman A
    Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
    Ledl A; Schmidt D; Müller S
    Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.
    Hermonat PL; Santin AD; Zhan D
    J Hum Virol; 2000; 3(3):113-24. PubMed ID: 10881991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the HPV E7 proteins with the pCAF acetyltransferase.
    Avvakumov N; Torchia J; Mymryk JS
    Oncogene; 2003 Jun; 22(25):3833-41. PubMed ID: 12813456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells.
    Banks L; Edmonds C; Vousden KH
    Oncogene; 1990 Sep; 5(9):1383-9. PubMed ID: 2216461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chaperone holdase activity of human papillomavirus E7 oncoprotein.
    Alonso LG; Smal C; Garcia-Alai MM; Chemes L; Salame M; de Prat-Gay G
    Biochemistry; 2006 Jan; 45(3):657-67. PubMed ID: 16411741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HPV-16 E7 oncoprotein binds Skip and suppresses its transcriptional activity.
    Prathapam T; Kühne C; Banks L
    Oncogene; 2001 Nov; 20(52):7677-85. PubMed ID: 11753645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein.
    Berezutskaya E; Yu B; Morozov A; Raychaudhuri P; Bagchi S
    Cell Growth Differ; 1997 Dec; 8(12):1277-86. PubMed ID: 9419416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
    Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
    Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A region of SV40 large T antigen can substitute for a transforming domain of the adenovirus E1A products.
    Moran E
    Nature; 1988 Jul; 334(6178):168-70. PubMed ID: 2968523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of S phase and apoptosis by the human papillomavirus type 16 E7 protein are separable events in immortalized rodent fibroblasts.
    Alunni-Fabbroni M; Littlewood T; Deleu L; Caldeira S; Giarrè M; Dell' Orco M; Tommasino M
    Oncogene; 2000 May; 19(19):2277-85. PubMed ID: 10822378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissimilar immunogenicities of human papillomavirus E7 and adenovirus E1A proteins influence primary tumor development.
    Routes JM; Ryan S; Li H; Steinke J; Cook JL
    Virology; 2000 Nov; 277(1):48-57. PubMed ID: 11062035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.